First of all @The Yankee, so good to see you back contributing. Experience tells us you have much to offer. Please keep us informed of what's happening in USA. Welcome.
Now, as to Gilead's Remdesivir, the name tells me it probably is an anti-viral. Something to kill Covid-19. Good luck to them. We need it. Not competition for MSB's Remstemcel-L,
I'm sure you know but some here might need the focus, Remstemcel-L treats ARDS. ARDS is the highly fatal condition that some sufferers from Covid-19 might acquire. And many of them will die. Not every one who contracts Covid-19 will get ARDS. But there will be plenty enough to make it a big earner for MSB.
And Covid-19 is not the only thing that causes ARDS. Plenty of market and marketing for MSB.
I think the big gainer for MSB from this is the commanding of respect from fundies. They will see the credibility of the science, the colossal breadth of application to all health issues, and the genius of SI and associates who have tied this up in multiple patents in every significant market in the world.
Is there anyone who cannot see this new paradigm unfolding?
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.32 |
Change
-0.090(3.73%) |
Mkt cap ! $2.956B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.35 | $2.15 | $22.38M | 9.861M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 33073 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.32 | 31559 | 27 |
View Market Depth
| Last trade - 13.15pm 21/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |